INNOVUS PHARMACEUTICALS, INC. — Net Income by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/a90540ec-2259-4227-b68d-0439b45700a2/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2018 | $-8.3M | 2018-01-01 – 2018-12-31 | evidence 0001437749-19-006219 |
| FY 2017 | $-6.5M | 2017-01-01 – 2017-12-31 | evidence 0001437749-19-006219 |
| FY 2016 | $-13.7M | 2016-01-01 – 2016-12-31 | evidence 0001654954-17-001819 |
| FY 2015 | $-4.2M | 2015-01-01 – 2015-12-31 | evidence 0001415889-16-005397 |
| FY 2014 | $-4.8M | 2014-01-01 – 2014-12-31 | evidence 0001415889-15-001153 |
| FY 2013 | $-6.5M | 2008-10-31 – 2013-12-31 | evidence 0001144204-14-018763 |
| FY 2012 | $-2.9M | 2008-11-01 – 2013-03-31 | evidence 0001144204-13-028024 |
| FY 2011 | $-2.4M | 2008-10-31 – 2012-03-31 | evidence 0001144204-12-027544 |
| FY 2010 | $-69.9k | 2010-01-01 – 2010-12-31 | evidence 0001144204-12-018381 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
INNOVUS PHARMACEUTICALS, INC. — all facts · Revenue · Operating Income